ADDICTION OPIOID ADDICTION

Size: px
Start display at page:

Download "ADDICTION OPIOID ADDICTION"

Transcription

1 ADDICTION OPIOID ADDICTION

2 DRUG ADDICTION Take Home Points 1 Drug addic=on is impossible to avoid in your prac=ce 2 Huge burden on economy, families, society 3 Drug addic=on is Treatable drug addicts deserve treatment and compassion 4 Addic=on medicine is the most rewarding field of medicine 5 How not to contribute to the problem

3 Addicts in the Workforce In 2009, current drug users over 18 were 67% were employed 48% employed full-=me 19% employed part-=me 13% unemployed 21% not in the labor force Source: Office of Na=onal Drug Control Policy

4 KAISER FAMILY FOUNDATION HEALTH TRACKING POLL (Nov ) Of people responding to the survey: 6% had abused painkillers 25% had friend/family abusing painkillers 45% knew people who abused painkillers 39% knew someone who became addicted 16% knew people who died from an overdose 9% lost a rela=ve or good friend to overdose. 56% of Americans touched by prescrip=on painkiller addic=on.

5 Economic Burden of Addic=on In 2007 $120 Billion in lost produc=vity Labor par=cipa=on, drug abuse treatment, incarcera=on, early death $11 Billion in medical costs $61 Billion in criminal jus=ce costs $193 Billion Source: Office of Na=onal Drug Control Policy

6 Economic Burden of Addic=on The total es=mated cost of diabetes in 2007: $116 billion in excess medical expenditures $58 billion in reduced na=onal produc=vity. $174 billion Total Economic cost of addicqon in 2007 was $193 billion

7 Cost of Substance Abuse Cost in Billions of US Dollars (2013)

8 What is AddicQon? Not the same thing as Physical Dependence Most addicts don t know the difference Many addic=ons have minimal physical dependency cocaine methamphetamine gambling

9 What is AddicQon? Not simply a mafer of Bad Choices

10 WHO PUT A GUN TO YOUR HEAD TO USE DRUGS?

11 WHO PUT A GUN TO YOUR HEAD TO EAT THAT JELLY DONUT?

12 What is AddicQon? Addic=ons are NOT Ra=onal

13 What is AddicQon? Addic=on is a Brain Disorder

14 What is AddicQon? Addic=on is a Brain Disorder

15 What is AddicQon? Addic=on is a Brain Disorder RegulaQng Brain temperature sleep/wake hunger/sa=ety pulse/respira=on rate electrolytes etc

16 What is AddicQon? Addic=on is a Brain Disorder RegulaQng Brain existen=al threats opioid withdrawal = regula=ng brain gone amok no temporal dimension

17 HOW TO DEAL WITH ADDICTS Treat addic=on as a disease Treat addicts as pa=ents, not as criminals Do not judge, do not abandon

18 HOW TO DEAL WITH ADDICTS

19 Practice Guidelines Respect Your Pa=ent Respect Opioids Respect Your Profession

20 Practice Guidelines Respect Your Pa=ent Compassion Most addicts have suffered terrible misfortunes They deserve & need our care, not our disdain See them as people They have parents, children, and other loved ones

21 Practice Guidelines Respect Opioids Pain kills no one Painkillers kill more than 3 people a day in Indiana Comparison with other drugs taken off market Baycol: 31 deaths Propulsid: 70 deaths Rezulin: 63 deaths

22 Practice Guidelines Respect Opioids

23 Practice Guidelines Respect Opioids

24 Practice Guidelines Respect Opioids Even short-term use for acute pain RelaQonship Between Early Opioid Prescribing for Acute OccupaQonal Low Back Pain and Disability DuraQon, Medical Costs, Subsequent Surgery and Late Opioid Use Webster, Barbara S., Verma, Santosh K., Gatchel, Robert J. Spine 2007, 32(19), pp claimants from a large WC database with new-onset, disabling LBP that occurred between January 1, 2002 and December 31, Separated into quin=les based on opioid exposure over the first 15 days (0, 1 140, , , 450+). [Note: highest group of 450 MEA = Norco 7.5 qid for 15 days]

25 Practice Guidelines Respect Opioids Webster et al. Spine 2007, 32(19) 2127

26 Practice Guidelines Respect Opioids Webster et al. Spine 2007, 32(19) 2127

27 Practice Guidelines Respect Opioids Webster et al. Spine 2007, 32(19) 2127

28 Practice Guidelines Respect Opioids Webster et al. Spine 2007, 32(19) 2127

29 Practice Guidelines Respect Opioids Addic=on poten=al Even short courses of opioids can lead to addic=on

30 Practice Guidelines Respect Your Profession Primum Non Nocere First, Do No Harm

31 Practice Guidelines Respect Your Profession If you idenqfy potenqal addicqon Treat the pa=ent with dignity Do not fire them or abandon them to their own devices (due to your own discomfort) Generally safe to taper and discon=nue pain medica=ons while making a referral Treat their other medical condi=ons as with any other pa=ent In other words, just be a doctor!

32 Practice Guidelines Respect Your Profession Learn more about addic=on medicine Least understood area of medicine Most rewarding field of medicine

33 Treatments for Opioid AddicQons 4 strategies: Non-medica=on assisted therapy Methadone Clinics Buprenorphine maintenance Naltrexone vivitrol injec=ons

34 Treatments for Opioid AddicQons Non-MedicaQon Assisted Therapy Detox - NOT sufficient! Rehab Counseling 12-step programs

35 Methadone Clinics Word on the street: It s worse than heroin It gets into your bones It s just switching one addic=on for another It s too expensive Truth is: Decreases fatal overdoses Reduces HIV/Hepa==s Fewer arrests Many are able to hold down a job COST ~$300/month

36 Methadone for Pain Benefits: Cheap, long-ac=ng Befer for neuropathic pain? Why It s Dangerous: 5% of the pain market; 40% of fatal overdoses Suppresses breathing longer than pain Unpredictable pharmacodynamics and variable half-life Drug-drug interac=ons QTc prolonga=on No safe opioid conversion What you need to know: No special license needed to con=nue methadone for inpa=ents Be careful with drug interac=ons

37 BUPRENORPHINE Par=al agonist can precipitate withdrawal ceiling agonist effect (INSPECT claims 300%MED) less respiratory depression special X-license needed to prescribe for addic=on works for pain but off-label

38 Suboxone = Buprenorphine + Naloxone Maintenance vs. Detox Other prepara=ons: generic buprenorphine/naloxone zubsolv bunavail Buprenorphine only: buprenex (IM/IV) subutex (buprenorphine HCl)

39 What To Do For Hospitalized PaQents on Buprenorphine Call the buprenorphine provider! Run an INSPECT report and get a urine drug test If pa=ents on suboxone need short-term pain relief, buprenorphine works for pain 1. X-licenses not necessary for inpa=ents not necessary to stop suboxone 2. possible strategies: increase suboxone : change to straight buprenorphine : add hydromorphone

40 hfps://

41 Title 21 CFR - Part Sec=on (c) This sec=on is not intended to impose any limita=ons on a physician or authorized hospital staff to administer or dispense narco=c drugs in a hospital to maintain or detoxify a person as an incidental adjunct to medical or surgical treatment of condi=ons other than addic=on, or to administer or dispense narco=c drugs to persons with intractable pain in which no relief or cure is possible or none has been found azer reasonable efforts. Administer/Dispense Prescribing

42 VIVITROL (NALTREXONE) Opioid antagonist Indicated for alcohol dependency as well as opioid dependency Once a month shot No special DEA license needed

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Medica8on Assisted Treatment (MAT) in Jails and Community- Based SeDngs

Medica8on Assisted Treatment (MAT) in Jails and Community- Based SeDngs Medica8on Assisted Treatment (MAT) in Jails and Community- Based SeDngs Lisa Ramirez, Lead Program Specialist, Texas Department of State Health Services, Mental Health and Substance Abuse Division Rebecca

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

Vivitrol Drug Court and Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP THA Medication Safety Summit Wesley Geminn, PharmD, BCPP Current Trends: Overdose Deaths in 2017 72,000 Or 197 per day 8 per hour National Opioid Overdose Statistics https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates

More information

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are

More information

The Social Worker s Role in Medication Assisted Treatment

The Social Worker s Role in Medication Assisted Treatment The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment

More information

Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital

Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital August 28, 2018 Hosted by John A. Renner, Jr., MD, DLFAPA Professor of Psychiatry Boston University

More information

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased

More information

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities 10/26/15 Perspec'ves on maternal opioid use and abuse Dr. Rita J. Nutt Our Expectation Harsh Realities 1 Opioid Abuse and Dependence Statistics, 2013 4.5 million people in the US current non- medical users

More information

Medication-Assisted Treatment (MAT) Overview

Medication-Assisted Treatment (MAT) Overview Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for

More information

2004-L SEPTEMBER

2004-L SEPTEMBER BULLETIN INTELLIGENCE Buprenorphine: Potential for Abuse Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III

More information

TELEPHONE SCREENING DEMOGRAPHIC INFO

TELEPHONE SCREENING DEMOGRAPHIC INFO TELEPHONE SCREENING Provider Name: Provider Signature: Date: How did you hear about the hotline? DEMOGRAPHIC INFO 1 = Spouse 2 = Friend 3 = Medical Provider 4 = Flyer 5 = Parent 6 = State Hotline 7 = Physician

More information

Strategies to Manage The Opioid Crisis

Strategies to Manage The Opioid Crisis Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South

More information

Vivitrol/Suboxone. Comparison Study Summary

Vivitrol/Suboxone. Comparison Study Summary Vivitrol/Suboxone Comparison Study Summary Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., & King, J. (2017). Comparative effectiveness of extended-release naltrexone versus

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

Buprenorphine addiction

Buprenorphine addiction Buprenorphine addiction Search 16-11-2013 High hopes for buprenorphine, an effective treatment for opioid addiction, have been tempered by a messy reality: health complications and deaths. The ATTC Network

More information

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description

More information

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction Thank you, Chairman Rogers, for holding this important Summit and helping to bring attention

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

HARM REDUCTION & TREATMENT. Devin Reaves MSW

HARM REDUCTION & TREATMENT. Devin Reaves MSW HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that

More information

Comba&ng overdose and opioid poisoning death among people experiencing homelessness

Comba&ng overdose and opioid poisoning death among people experiencing homelessness James Kowalsky & Maya Doe- Simkins Midwest Harm Reduc0on Ins0tute Na&onal Health Care for the Homeless Conference & Policy Symposium May 28, 2014 Comba&ng overdose and opioid poisoning death among people

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

Vivitrol Vs. Suboxone

Vivitrol Vs. Suboxone Vivitrol Vs. Suboxone Vivitrol - Naltrexone Indicated for opiate dependence and alcohol withdrawal pure antagonist 380mg once every 4 weeks IM Peak plasma concentration in 2 hrs, followed by a second peak

More information

Opioid Replacement Therapy

Opioid Replacement Therapy Opioid Replacement Therapy Matthew A. Felgus, MD mafelgus@wisc.edu 6333 Odana Rd, Suite 3, Madison, WI 53719 (608) 257-1581 Board Certified in Addiction Medicine Board Certified in Psychiatry matthewfelgusmd.com

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

Medication-Assisted Treatment (MAT) for Opioid Use Disorders

Medication-Assisted Treatment (MAT) for Opioid Use Disorders Medication-Assisted Treatment (MAT) for Opioid Use Disorders Sybil Marsh MA MD FASAM Department of Family Medicine and Community Health Case Western Reserve University/UHCMC Learning Objective 1 Following

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O. Evolving Treads in Medication Assisted Treatment Christopher J Davis D.O. CAADC, FASAM Medical Director, The Ranch of Pennsylvania Medical Director, Pyramid Healthcare Diplomate of The American Board of

More information

Recognizing Narcotic Abuse and Addiction and Helping Those With It

Recognizing Narcotic Abuse and Addiction and Helping Those With It Recognizing Narcotic Abuse and Addiction and Helping Those With It Michael McNett, MD Medical Director for Chronic Pain Member, WI Med Society Opioid Subcommittee Ancient History 1995: OxyContin approved

More information

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services www.randallwebber.com MAT clients are still addicted Truth: MAT clients will experience withdrawal symptoms if they stop

More information

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets Risk Evaluation and Mitigation Strategy (REMS) Program Office-Based Buprenorphine Therapy for Opioid Dependence: Important Information for Prescribers

More information

NURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time?

NURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time? NURSING INTAKE Provider Name: Provider Signature: Date: Nursing Summary Are you pregnant at this time? 3 = Don t know 4 = Tubal ligation 5 = Menopause 6 = History of hysterectomy 7 = Other: 8 = N/A patient

More information

Treating Opioid Addiction

Treating Opioid Addiction Treating Opioid Addiction Some people who start taking opioid pain medications eventually have serious problems with them and become addicted. Every day, 68 people die in the US from opioid overdose. More

More information

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.32 Subject: Suboxone Drug Class Page: 1 of 7 Last Review Date: June 24, 2016 Suboxone Drug Class Description

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874

More information

Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical

Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical Officer, Interval Brotherhood Home, Akron, OH Director

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

Understanding Medication in Addiction Treatment for Drug Court Participants

Understanding Medication in Addiction Treatment for Drug Court Participants Understanding Medication in Addiction Treatment for Drug Court Participants Introduction This pocket guide is for drug court participants who may be prescribed or considering medication as a part of addiction

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Alexander Y. Walley, MD, MSc Associate Professor of Medicine Director, Addiction Medicine Fellowship Boston University

More information

2/21/2018. What are Opioids?

2/21/2018. What are Opioids? Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting

More information

Buprenorphine treatment

Buprenorphine treatment South London and Maudsley NHS Foundation Trust Buprenorphine treatment Information for service users Page Buprenorphine treatment What is buprenorphine? Buprenorphine (trade name Subutex ) is an opioid

More information

OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS

OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS LEO O. LANOIE, MD, MPH, FCFP, CCSAM, ABAM, FISAM, MRO Dr. Leo Lanoie, 2017 DISCLAIMER In the past year I have accepted funds from Purdue for speaking OPIOID

More information

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICAL DIRECTOR, UNITYPOINT HEALTH MERITER/ NEWSTART ADJUNCT PROFESSOR, UNIVERSITY OF WISCONSIN MADISON

More information

Patient Information Leaflet

Patient Information Leaflet Page 25 Patient Information Leaflet PATIENT INFORMATION SUBOXONE (sub-ox-own) (buprenorphine HCl/naloxone HCl dihydrate, sublingual tablet) (C*) SUBUTEX (SUB-u-tex) (buprenorphine HCl, sublingual tablet)

More information

Five Things the Family Physician Needs to Know about Addiction and Harm Reduction

Five Things the Family Physician Needs to Know about Addiction and Harm Reduction Five Things the Family Physician Needs to Know about Addiction and Harm Reduction Dr. Sharon Koivu Palliative Care Physician Consultant, London Health Sciences Centre, Department of Family Medicine, Western

More information

Opioid Use Disorders &Medication Treatment

Opioid Use Disorders &Medication Treatment Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine [Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com

More information

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

7/7/2016 Journal of the American Medical Association,

7/7/2016 Journal of the American Medical Association, 1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of

More information

Buprenorphine pharmacology

Buprenorphine pharmacology Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely

More information

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR Practical Tools to Successfully Taper Prescription Opioids Melissa Weimer, DO, MCR Objectives Understand how to calculate morphine equivalents per day Understand the steps necessary to plan a successful

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016 The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of

More information

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction Avoid compassion traps Do you want me to lose my job, do you want me to be on the street? I want you to have safe and effective pain control and it is my medical opinion that your current medicine won

More information

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained

More information

A prisoners guide to buprenorphine

A prisoners guide to buprenorphine A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw

More information

Management Options for Opioid Dependence:

Management Options for Opioid Dependence: Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice

More information

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots

More information

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in

More information

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded access to naloxone, overdose education, prevention,

More information

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene

More information

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

the facts about BUPRENORPHINE for Treatment of Opioid Addiction the facts about BUPRENORPHINE for Treatment of Opioid Addiction i I d been shot on the streets, I d been in detox. It was jails, institutions. Death, I knew, was imminent for me so I started my recovery

More information

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine

More information

OPIOID REPLACEMANT THERAPY: AN OVERVIEW

OPIOID REPLACEMANT THERAPY: AN OVERVIEW OPIOID REPLACEMANT THERAPY: AN OVERVIEW Matthew Felgus MD FASAM Matthew A Felgus, MD, FASAM mafelgus@wisc.edu matthewfelgusmd.com 6333 Odana Rd, Ste 3, Madison WI 53719 (608) 257-1581 Board Certified in

More information

Overview of Opioid Use Disorder

Overview of Opioid Use Disorder Overview of Opioid Use Disorder Doug Burgess, MD Medical Director of Outpatient Services, Truman Medical Centers Assistant Professor of Psychiatry, University of Missouri- Kansas City Objectives History

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

Buprenorphine as a Treatment Option for Opioid Use Disorder

Buprenorphine as a Treatment Option for Opioid Use Disorder Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital

More information

Ohio Council on Family Relations What s Up With Opiates? 2.0. BY: Philip Atkins, PhD, LICDC-CS,OCPC Executive Director Mental Health & Recovery Board

Ohio Council on Family Relations What s Up With Opiates? 2.0. BY: Philip Atkins, PhD, LICDC-CS,OCPC Executive Director Mental Health & Recovery Board Ohio Council on Family Relations What s Up With Opiates? 2.0 BY: Philip Atkins, PhD, LICDC-CS,OCPC Executive Director Mental Health & Recovery Board Who We Are. www.oacbha.org Setting the Context Where

More information

Methadone and Naltrexone ER

Methadone and Naltrexone ER Methadone and Naltrexone ER Laura G. Kehoe, MD, MPH, FASAM Medical Director MGH Substance Use Disorder Bridge Clinic Assistant Professor of Medicine Harvard Medical School Disclosures Neither I nor my

More information

Medication Assisted Treatment as an alternative in Drug Courts*

Medication Assisted Treatment as an alternative in Drug Courts* Medication Assisted Treatment as an alternative in Drug Courts* National Drug Court Institute *portions of this presentation include adapted slides by Frances Levin, MD, Joshua Lee, MD, & Laurence Westreich,

More information

Recovery U: Medication Assisted Treatment (MAT)

Recovery U: Medication Assisted Treatment (MAT) Recovery U: Medication Assisted Treatment (MAT) MS. TIKKANEN: Welcome to the Recovery U Online Learning Community for Understanding Medication-Assisted Treatment. This is Skye Tikkanen. I am a clinical

More information

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit AODA RECOVERY How to support those in recovery, and those not yet ready to commit YOUR PRESENTER TODAY Robin Lickel is a psychotherapist and addictions specialist at Journey Mental Health Center in Madison,

More information

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4. How serious a public health problem in the State of New York is each of the following: [Q1A-Q1I ROTATED] Q1A. Alcohol abuse Very serious 61% 63% 53% 63% 36% 71% 52% Somewhat serious 35% 35% 38% 33% 52%

More information

The Latest Prescription Trends for Controlled Prescription Drugs

The Latest Prescription Trends for Controlled Prescription Drugs The Latest Prescription Trends for Controlled Prescription Drugs September 1, 2015 Christopher M. Jones PharmD, MPH Senior Advisor Office of Public Health Strategy and Analysis Office of the Commissioner

More information

MEDICATION ASSISTED TREATMENT

MEDICATION ASSISTED TREATMENT MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone

More information

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand

More information

MEDICATION Assisted Treatment

MEDICATION Assisted Treatment Matthew A Felgus, MD FASAM mafelgus@wisc.edu matthewfelgusmd.com 6333 Odana Rd, Ste 3, Madison WI 53719 (608) 257-1581 Board Certified in Addiction Medicine Board Certified in Psychiatry MEDICATION Assisted

More information

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment This booklet was created to help you learn about opioids. You probably have lots

More information

9/13/2017. Buprenorphine Treatment (Suboxone) Disclosures. We ve Got a Big Opioid Problem. Selahattin Kurter, MD Spectrum Healthcare

9/13/2017. Buprenorphine Treatment (Suboxone) Disclosures. We ve Got a Big Opioid Problem. Selahattin Kurter, MD Spectrum Healthcare Buprenorphine Treatment (Suboxone) Selahattin Kurter, MD Spectrum Healthcare Board Certified in Psychiatry and Addiction Medicine Disclosures No financial reimbursement for this lecture Consultant for

More information

Pregnancy, MAT and Addiction

Pregnancy, MAT and Addiction Pregnancy, MAT and Addiction Carl Christensen, MD, PhD, D-FASAM Clinical Associate Professor, OB Gyn & Psychiatry Wayne State University School of Medicine William Morrone, DO, MPH, DABAM Covenant Hospital

More information

Understanding and Combating the Heroin Epidemic

Understanding and Combating the Heroin Epidemic Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the

More information

Latest Press Release. How much for 30 mg adderall

Latest Press Release. How much for 30 mg adderall corp@stantec.com Latest Press Release How much for 30 mg adderall S 14-2-2008 Hi my name is Rachel i have been on suboxone for almost a year as of OCT 1st, and I have become the person I guess I am to

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Appraisal Methadone and buprenorphine for the management of opioid dependence Comments received from Consultees and Commentators on the draft scope

More information

Opportunities for Opioid Safety and Community-Based Overdose Management

Opportunities for Opioid Safety and Community-Based Overdose Management Opportunities for Opioid Safety and Community-Based Overdose Management DANTE COLLINS ERICA C. ERNST MAYA DOE-SIMKINS SEPTEMBER 13, 2013 Overview Prevalence & data Overdose prevention Making an overdose

More information